Carbon Biosciences

Carbon Biosciences
Carbon Biosciences is expanding the therapeutic potential of gene therapy through its proprietary platform which leverages novel parvoviruses that have been pressure tested by nature to target specific tissues, carry a larger cargo, with minimal neutralizing immunity and the potential to re-dose.
Total raised: $38M

Investors 1

Funding Rounds 1

DateSeriesAmountInvestorsDeal News
22.06.2022Series A$

Mentions in press and media 1

22.06.2022Carbon Bio...Carbon Biosciences, a Boston,